This white paper reviews U.S. Federal Trade Commission settlements that have required increasingly specific remedies since the pivotal 2018 LabMD case. The paper provides a contextualization of why certain technologies like multifactor authentication are now stipulated in some FTC settlements, and if organizations should begin implementing technologies promoted by the commission, even if they have not yet been stipulated in a settlement order.